Aim: To investigate the effect of diallyl disulfide (DADS), a component of garlic, on apoptosis in human mammary cancer cell line (MCF-7) and its mechanisms. Methods: Cytotoxicity was analyzed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays. Morphology of apoptotic cells was detected by acridine orange and ethidium bromide staining. Apoptotic cells stained with propidium iodide were examined using flow cytometry. Protein levels were detected by Western blot analysis. Results: DADS inhibited the proliferation of MCF-7 cells and induced the apoptotic ratio to increase rapidly. Cleavage of the caspase-3 and caspase-3 substrate poly(ADP-ribose) polymerase was observed in MCF-7 cells after 24 h of treatment with DADS. When the MCF-7 cells were treated with 200 µmol·L -1 DADS, the stress-activated protein kinase extracellular signal-regulated kinase (ERK), a mitogen-activated protein kinase, was inhibited after 6 h; c-Jun N-terminal kinase (JNK), that is stress-activated protein kinase (SAPK), and p38 mitogen-activated protein kinase were activated after 6 h. Conclusion: These results suggest that DADS both inhibits the proliferation of MCF-7 cells and induces apoptosis of MCF-7 cells. The mechanisms may include the inhibition of ERK and the activation of the SAPK/JNK and p38 pathways.
Introduction
Breast cancer is one of the most common malignancies in women and is the leading cause of death worldwide for women between the ages of 40 and 55 years. If effective chemopreventive treatment for breast cancer could be developed, it would have a significant impact on breast cancer morbidity and mortality [1] . However, breast cancer cells are highly resistant to chemotherapy and there is still no effective cure for patients with advanced disease, especially in cases of hormone-independent breast cancer [2, 3] . A promising new approach to this problem is the use of garlic. A high intake of garlic is associated with a protective effect against various cancers in humans. Several epidemiological studies suggest that garlic is associated with a decrease of the tumor fatality rate [4] .
Garlic oil, or more specifically the diallyl disulfide (DADS) it contains, has recently become more appealing as an anticarcinogenic agent, in part due to its ability to induce apoptosis in vitro [5] and inhibit the formation and growth of tumors in vivo [6, 7] . Generally, it is the lipidsoluble organic compounds in garlic that are the most effective antiproliferative agents, and many of them have warranted further study as antitumorigenic agents [8] . Several studies have already demonstrated the efficacy of garlic compounds as antitumorigenic agents. For example, DADS inhibits the in vitro growth of colon, lung and gastric cancer cell lines, and leukemia cell lines [9] [10] [11] , indicating that DADS may be a useful therapeutic tool in the prevention of cancers. However, a systematic, detailed study of the effects of DADS on human breast cancer cells has yet to be performed. Thus the primary objective of our study was to examine the effect of DADS on human mammary cancer cell line MCF-7.
A secondary objective was to explore the possible mechanisms for any anticancer effects of DADS. One possibility is that DADS promotes apoptosis, and several signaling pathways have been implicated in the regulation of neuronal apoptosis [12] . These include the extracellular signal-regulated protein kinase (ERK) 1/2, the c-Jun NH 2 -terminal protein kinase (JNK), and the p38 mitogen-activated protein kinase (MAPK). ERK1/2 are preferentially activated by growth factors and neurotrophic factors, while JNK and p38 are preferentially activated by cell stress-inducing signals, such as oxidative stress, environmental stress, and toxic chemical insults [13, 14] . Much attention has been focused on the MAPK pathway as a possible target for newly-designed antineoplastic drugs. Therefore, it is useful to establish the role that the MAPK pathway plays in the process that leads to differentiation within a specific tissue or cell type. In our study, ERK, p53, and JNK activity were observed after DADS-induced differentiation in the human breast cancer cell line MCF-7.
Materials and methods

Drugs and reagents
The breast cancer cell line MCF-7 was provided by the Cancer Research Institute of Xiangya Medical School of Central South University (Changsha China). DADS was purchased from Sigma (St Louis, MO, USA), RPMI-1640 from Gibco (Grand Island, NY, USA), and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) from Amresco (Solon, OH, USA). DMSO, PD98059 (a specific p42/44 MAPK cascade inhibitor), and SDS were purchased from Sigma (USA). Anticaspase-3, JNK, phospho-JNK, ERK, phospho-ERK, phospho-p38, p38, horseradish peroxidase-conjugated second antibody, and enhanced chemiluminescence reagents were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antipoly(ADP-ribose) polymerase (PARP) was obtained from Cell Signaling (Beverly, MA, USA). The annexin Vfluorescein isothiocyanate (FITC) apoptosis detection kit was purchased from Calbiochem (San Diego, CA, USA).
Cell culture The MCF-7 cells were maintained in RPMI-1640 medium supplemented with 10% fetal bovine serum, 1×10
7 IU·L -1 penicillin, and amphotericin in a 37 o C humidified incubator with an atmosphere of 5% CO 2 .
Treatments A 50 µmol·L -1 solution of DADS was prepared just before each experiment by dissolving DADS in DMSO. Treatments included different concentrations of DADS ranging from 50 to 400 µmol·L -1 at 37 °C in medium supplemented with serum. For the apoptosis studies, we used 200 µmol·L -1 DADS because that particular concentration induces a significant degree of apoptosis at the times selected, and because it is in the range used for in vivo studies. As a control, an equal amount of DMSO (0.1%) was added to the untreated cells.
Cell viability assay The cells were seeded into 96-well plates and grown to 80% confluence in RPMI-1640. The cultures were then rinsed and incubated with their respective test substances for 24 h. Cell viability was measured using the MTT assay. MTT was dissolved in 1.0 mL phosphate buffered saline (PBS). An amount of this solution equal to 100 mL·L -1 of the culture medium volume was added to the cell cultures. After 6 h of incubation, the cultures were removed from the incubator and the formazan crystals were solubilized by adding DMSO. Metabolic activity was quantified by measuring light absorbance at 570 nm [15] . Ethidium bromide and acridine orange staining The MCF-7 cells treated with different concentrations of DADS were cocultured in 24-well plates for 24 h. PBS (0.9 mL) was mixed with 50 mL ethidium bromide (Sigma, USA) and acridine orange (Amersco, USA) in a 1 mL tube. The cells were then observed under a fluorescence microscope (Olympus, Tokyo, Japan) with a FITC filter set. A total of 200 cells were counted per sample. The percentage of apoptotic cells was calculated by adding the total number of apoptotic living (AL) and apoptotic dead (AD) cells, dividing it by the total number of cells and multiplying it by 100. The percentage of calculated apoptotic cells was as follows:
Apoptosis %=(VA+NVA)/total cell count×100% [16] , where VA is viable apoptotic cell, and NVA is non-viable apoptotic cell.
Flow cytometry Cells exposed to different treatments were collected and resuspended in RPMI-1640 medium supplemented with 10% fetal bovine serum. The cell suspension was adjusted to approximately 1×10 9 cells·L -1
. The cells (0.5 mL of the cell suspension) were transferred to a microfuge tube, incubated at room temperature for 15 min in the dark and centrifuged; the media were then removed. After being resuspended in 0. 5 [17] . Western blot analysis After treatment, the cells were removed from the plates and lysed with buffer (5×10 4 µmol·L -1 leupeptin. After the lysates were cleared by centrifugation at 15 000×g for 20 min at 4 °C, the total protein was determined using a Bio-Rad protein assay solution (Hercules, CA, USA). Up to 75 g of total protein was denatured in SDS sample loading buffer for 5 min at 95 °C, separated on 10%-15% SDS-PAGE gels, and electro-transferred to Immobilon-P membranes (Millipore, Bedford, MA, USA) using semidry electrophoretic transfer. After the non-specific binding sites on the membranes were blocked with 5% skimmed milk or BSA in TBS-T (2×10 4 µmol·L -1 Tris-HCl, pH 7.5, 1.37×10 2 µmol·L -1 NaCl, and 0.01% Tween 20) for 3 h at room temperature with constant shaking, the membranes were incubated in TBST containing the relevant primary antibody (1:500-1000) and 5% BSA overnight at 4 °C. After washing with TBST 3 times, the membranes were incubated in 5% skimmed milk in TBST buffer containing the appropriate second antiimmunoglobulin G antibody (1:5000) at room temperature for 1 h with constant shaking. For the normalization of protein loading, the same membranes were stripped with stripping buffer (1×10 5 µmol·L -1 2-mercaptoethanol, 2% SDS, and 6.25×10 4 µmol·L -1 Tris-HCl, pH 6.7) and used for the Western blot assays by the same procedure with a monoclonal antibody against β-actin (1:1000 dilution) and/ or with polyclonal antibodies against the relevant protein.
Results
Cell viability
The MCF-7 cells were plated at a density of 5000 cells/well into 96-well plates. DADS was added to the wells. The cells were cultured for 24 h and the MTT assay was run. As shown in Figure 1 , DADS was found to inhibit the growth of MCF-7 cells in a dose-dependent manner. The treatment of MCF-7 cells for 24 h with 50, 100, 200, 300, or 400 µmol·L -1 DADS resulted in growth inhibition. Survival rates were 99.95%, 91.13%, 83.79%, 59.3%, and 52.56%, respectively (P<0.05; Figure 1) . . The cells were collected and stained with propidium iodide and analyzed by flow cytometry. As shown in Figure 3 , the proportion of propidium iodide cells increased from 3.74% to 9.22% to 20.2% to 42% in MCF-7 cells treated with the above concentrations of DADS. The value for the control group was 3.03% ( Figure 3) .
Cell morphology in MCF-7 cells treated by DADS
Cleavage of caspase-3 and PARP by DADS in MCF-7 cells
In this experiment, the MCF-7 cells were treated with different concentrations of DADS for 24 h. The cells were collected and lysed. Western blot analysis was conducted and probed with antibodies to caspase-3 or to PARP. To further confirm that apoptosis was induced by DADS, caspase-3 and PARP cleavages were detected by Western blot analysis. The results showed that procaspase-3 was cleaved to yield a 17 kDa fragmentation, and PARP was cleaved into an 89 kDa fragment following DADS treatment (Figure 4) .
Inhibition of ERK pathway by DADS
The MCF-7 cells were treated with 200 µmol·L -1 DADS for 6, 12, 24, or 48 h. The cells were analyzed by Western blotting with antiphospho-ERK or an anti-ERK antibody. We found that phospho-ERK decreased after treatment with DADS. The ERK1/2 protein level did not significantly change in the MCF-7 cells exposed to DADS ( Figure 5 ). PD98059, a specific p42/44 MAPK cascade inhibitor, reinforced the inhibition of phosphorylation by DADS, causing an increase in total ERK1/2 ( Figure 6 ). In parallel experiments, the amount of ERK was determined in the same cell extracts using an antibody that recognized all ERK isoforms, independent of their phosphorylation state.
Activation of stress-activated protein kinase/JNK and p38 pathways by DADS The MCF-7 cells were treated with 200 µmol·L -1 DADS for 6, 12, 24, or 48 h. The cells were harvested and lysed. The total protein (40 μg/lane) was loaded on an SDS-PAGE gel, transferred to a PVDF membrane, and probed with antibodies to phosphop38, p38, phospho-JNK, or JNK. Phospho-p38 and phospho-JNK increased with time. The protein levels of p38 and JNK did not change significantly in the MCF-7 cells exposed to DADS (Figures 7, 8 ).
Discussion
The objectives of this study were to determine if DADS induced apoptosis in a human breast cancer cell line (MCF-7) and to elucidate the underlying molecular mechanisms. In the present study, DADS was also proven to be an effective inhibitor of human estrogen-receptor ER-positive human breast cells, and our results indicate that DADS dose dependently induces growth inhibition in these cells. The growth inhibitory properties of DADS were also attributed to its induction of apoptotic cell death by the increased proportion of cells in the sub G 1 population [18] . The activation of caspase-3 is required for the induction of apoptosis induced by several different stimuli [19, 20] . DADS induced the cleavage of capspase-3 and PARP, indicating that caspase-3 was activated during the induction of apoptosis. DADS blocked PARP cleavage and reduced the number of classical apoptotic cell deaths after rotenone treatment. Many of the cells had shrunken nuclei and lacked chromatin fragmentation or condensation into discrete dense clumps [21] [22] [23] [24] . Taken together, these results suggest that DADS induces caspase-dependent apoptosis in MCF-7 cells.
Probing possible mechanisms for the above effects of DADS, we considered MAPK and ERK pathways and JNK and p38 signaling. These have a central role in transducing extracellular signals into cellular response [25] [26] [27] . ERK is the archetypal pathway of the MAPK superfamily. It is activated in response to a wide variety of growth factors and mitogens, and sustained activation eventually initiates cell proliferation and elicits hallmarks of transformation. Conversely, the inhibition of ERK has been shown to inhibit cell growth and growth factor-stimulated gene trans cription. In our system, DADS attenuated the phosphorylation levels of ERK. Thus the inhibition of ERK signaling by DADS might be an attractive explanation for the well-documented biochemical and morphological reverse of many cancer cells into a more benign phenotype following DADS treatment. PD98059 reinforced the inhibition of phosphorylation by DADS causing an increase in total ERK 1/2 levels. This increase may be related to a change in the expression of the ERK gene induced by PD98059. It is now necessary to do a systematic, detailed study of the effect of PD98059 and DADS on human breast cancer cells. DADS inhibits ERK1/2 in human gastric carcinoma MGC803 cells, which may be correlated with protein tyrosine phosphatases, which are frequently upregulated in association with decreased cell proliferation and terminal differentiation.
JNK and p38 signaling are implicated in responses to cellular stress, inflammation, and apoptosis [28] [29] [30] . JNK is commonly activated when cells are exposed to various stresses, such as growth factor withdrawal, chemotherapeutics, UV, and TNF-α. Furthermore, it was shown that JNK contributed to apoptotic signal transduction in response to various stressful stimuli. In our apoptotic system, DADS enhanced the phosphorylation levels of JNK and p38 in MCF-7 cells. The prolonged and persistent activation of JNK/stress-activated protein kinase (SAPK) and p38 and the inactivation of ERK induce apoptotic cell death.
In conclusion, these results suggest that DADS inhibits the proliferation of MCF-7 cells and induces apoptosis. The mechanisms may involve the inhibition of ERK and the activation of the SAPK/JNK and p38 pathways. 
